loading page

Treatment of refractory thrombotic thrombocytopenic purpura with Caplacizumab : A case report
  • +2
  • zakaria maat,
  • lana awad,
  • Mhd Baraa Habib,
  • Abdul Aziz Zafar. ,
  • afaf albattah
zakaria maat
Hamad Medical Corporation

Corresponding Author:[email protected]

Author Profile
lana awad
Hamad Medical Corporation
Author Profile
Mhd Baraa Habib
Hamad Medical Corporation
Author Profile
Abdul Aziz Zafar.
Hamad General Hospital
Author Profile
afaf albattah
Hamad Medical Corporation
Author Profile


Caplacizumab can be used as a treatment for TTP refractory to plasmapheresis and steroid
03 Sep 2021Submitted to Clinical Case Reports
05 Oct 2021Assigned to Editor
05 Oct 2021Submission Checks Completed
14 Oct 2021Reviewer(s) Assigned
24 Oct 2021Review(s) Completed, Editorial Evaluation Pending
24 Oct 2021Editorial Decision: Revise Minor
23 Dec 20211st Revision Received